Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: Netherlands Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20153
20162
20173
20182
20196
20208
202113
20228
20239
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Daiichi Sankyo4
Bristol-Myers Squibb3
GlaxoSmithKline3
Hoffmann-La Roche3
ArriVent BioPharma, Inc.2
Boehringer Ingelheim2
ETOP IBCSG Partners Foundation2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung61
Neoplasm Metastasis9
Lung Neoplasms6
Neoplasms6
Colorectal Neoplasms4
Ovarian Neoplasms3
Stomach Neoplasms3
Carcinoma2
Carcinoma, Renal Cell2
Endometrial Neoplasms2

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.